Stemline Therapeutics announces proposed public offering of common stock
Stemline Therapeutic announced it intends to offer and sell shares of its common stock in an underwritten public offering. Stemline intends to grant underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering. January 19, 2017